Results 61 to 70 of about 349,819 (308)

A mRNA Vaccine for Crimean–Congo Hemorrhagic Fever Virus Expressing Non-Fusion GnGc Using NSm Linker Elicits Unexpected Immune Responses in Mice

Viruses
Crimean–Congo hemorrhagic fever (CCHF), caused by Crimean–Congo Hemorrhagic virus (CCHFV), is listed in the World Health Organization’s list of priority diseases.
Tong Chen, Zhe Ding, Xuejie Li, Yingwen Li, Jiaming Lan, Gary Wong   +5 more
doaj   +1 more source

Elevated l-threonine is a biomarker for Lassa fever and Ebola

Virology Journal, 2020
Background Lassa fever and Ebola are characterized by non-specific initial presentations that can progress to severe multisystem illnesses with high fatality rates.
Trevor V. Gale, John S. Schieffelin, Luis M. Branco, Robert F. Garry, Donald S. Grant   +4 more
doaj   +1 more source

Clinical and pathologic features of Crimean-Congo hemorrhagic fever

, 2007
This chapter describes the story of the clinical process starting from the entrance of the virus to the human body to the death, if happens. Humans are the only known host of Crimean-Congo hemorrhagic fever virus (CCHFV) in which disease is manifested ...

core   +1 more source

Age and clinical dengue illness. [PDF]

, 2007
The relationship between age and risk for classic dengue fever has never been quantified. We use data from clinical patients to show that the relative risk of having classical disease after primary dengue virus infection increases with age.
Coleman, Paul G, Joseph R. Egger, Paul G. Coleman, Egger, Joseph R, Joseph R. Egger   +4 more
core   +1 more source

Inflammation Unchecked: Concurrent Kawasaki Disease and Stevens‐Johnson Syndrome in an 18‐Month‐Old Child

Arthritis Care &Research, EarlyView.
Catherine Deffendall, Jodi Backalar, Elizabeth Acevedo Zapata, Adriana Della Porta, Lorin Bibb, Tyler Reese, Charlotte M. Brown   +6 more
wiley   +1 more source

Duck Orbivirus and Egg Production: A Newly Identified Duck Orbivirus Is the Etiological Agent of Egg Production Decline in Chinese Breeder Ducks

Animal Research and One Health, EarlyView.
Field samples from breeder duck farms with egg‐production decline were subjected to viral detection, genome sequencing, and virus isolation. Experimental infection demonstrated that duck orbivirus (DORV) causes a significant and persistent reduction in egg production in breeder ducks.
Bing Li, Jianhua Wang, Xuezhi Cui, Xinxing Chu, You Wang, Dongmin Hao, Mingqing Xu, Haixia Chang, Huihui Li, Mingtian Mao, Mian Wu, Chengguang Lu, Jing Tang, Suyun Liang, Zhanbao Guo, Zhengkui Zhou, Youxiang Diao, Shuisheng Hou, Yi Tang   +18 more
wiley   +1 more source

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Imported viral haemorrhagic fever with a potential for person-to-person transmission: review and recommendations for initial management of a suspected case in Belgium.

, 2002
Viral haemorrhagic fevers are caused by a wide range of viruses. There are 4 types of viruses well known to spread from person to person and able to cause nosocomial outbreaks with a high case fatality rate: an arenavirus (Lassa fever and more ...
Borchert, M., Moreau, M, Borchert, M, Colebunders, R, Moreau, M., Van Esbroeck, M., Van Esbroeck, M, Colebunders, R.   +7 more
core   +1 more source

The early clinical features of dengue in adults: challenges for early clinical diagnosis. [PDF]

, 2011
BACKGROUND: The emergence of dengue throughout the tropical world is affecting an increasing proportion of adult cases. The clinical features of dengue in different age groups have not been well examined, especially in the context of early clinical ...
Chaterji, S., Lee-Ching Ng, Martin L. Hibberd, Chow, Angelia, Sharon W. S. Tan, Chua, C.R., Vasudevan Subhash G., Martin L Hibberd, Ooi Eng Eong, Leo Yee Sin, Choon Rong Chua, Chua Robert, Vasudevan, Subhash G, Chaterji, Shera, Leo, Yee Sin, Cheung, Yin Bun, Ng, Lee-Ching, Leo, Y.S., Chow, A., Ong Adrian, Cheung Yin Bun, Lim Wen Yan, Yin Bun Cheung, Chua Choon Rong, Adrian Ong, Yee Sin Leo, Low, Jenny GH, Hibberd, M.L., Subhash G Vasudevan, Low Jenny G. H., Ong, A., Cheung, Y.B., Ooi, E.E., Ng, L.-C., Low, J.G.H., Vasudevan, S.G., Jenny G. H. Low, Hibberd Martin L., Wen Yan Lim, Eng Eong Ooi, Tan Li Kiang, Lee, K.W., Jenny G H Low, Ong, Adrian, Lim, W.Y., Shera Chaterji, Chua, R., Koon Wui Lee, Tan Sharon W. S., Lim, Wen Yan, Ng Lee-Ching, Subhash G. Vasudevan, Lee Koon Wui, Robert Chua, Chaterji Shera, Ooi, Eng Eong, Hibberd, Martin L, Tan, L.K., Tan, S.W.S., Angelia Chow, Li Kiang Tan, Lee, Koon Wui, Tan, Sharon WS, Tan, Li Kiang, Sharon W S Tan, Chua, Choon Rong, Chua, Robert, Chow Angelia   +67 more
core   +2 more sources

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque‐Pereira, Christine Leopold, Patrick C. Souverein, Aukje K. Mantel‐Teeuwisse, Marie L. De Bruin   +6 more
wiley   +1 more source